Cancer News
Common malaria drug can enhance anti-cancer activity of chemotherapy An Indian-origin scientist has revealed that adding hydroxychloroquine (HCQ) - an FDA-approved drug used commonly for malaria and rheumatoid arthritis - to many cancer therapies, including chemotherapy, targeted therapy, radiation, and immunotherapy, can enhance the antitumor activity of these drugs in laboratory models of treatment-resistant cancers, and ongoing clinical trials.
Blocking autophagy-the
Cancer Galleries
Cancer Videos
|
|